FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 2827952 · Received November 12, 2012

Report

Report Number
1030489-2012-02074
Event Type
Injury
Date Received
November 12, 2012
Report Date
October 13, 2012
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE ARTICLE CITATION: DODWELL ET AL. OFF-LABEL USE OF BONE MORPHOGENETIC PROTEINS IN PEDIATRIC SPINAL ARTHRODESIS. JAMA; OCTOBER 10, 2012; VOL 308, NO. 14: 1429-1432. A2: PEDIATRIC. (B)(4): NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED IN A LITERATURE PUBLICATION THAT THE (B)(6), HEALTHCARE COST AND UTILIZATION PROJECT, WAS REVIEWED TO DETERMINE THE PREVALENCE OF BMP USE, ASSOCIATED COMPLICATIONS, COSTS, AND POTENTIAL PREDICTORS OF USE IN PEDIATRIC SPINAL ARTHRODESIS IN THE UNITED STATES. THE AUTHORS INCLUDED CHILDREN AGED 18 YEARS OR YOUNGER WHO HAD UNDERGONE PRIMARY OR REVISION SPINE ARTHRODESIS IN 2009. COMPLICATIONS ASSESSED INCLUDED MEDICAL, NEUROLOGICAL, WOUND HEALING, INFECTIOUS, AND THOSE RELATED TO BREATHING AND DYSPHAGIA. NATIONALLY, BMP WAS ESTIMATED TO BE USED IN 9.2% (95% CI, 7.3%-11.0%; UNWEIGHTED N=771) OF CASES. THE ESTIMATED PREVALENCE OF IN-HOSPITAL COMPLICATIONS IN THOSE WHO RECEIVED BMP WAS 24 PATIENTS AND IN THOSE WHO DID NOT RECEIVE BMP WAS 271.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention